Diagnostics, 2018 · DOI: 10.3390/diagnostics8030055 · Published: August 24, 2018
This study explores whether using contrast-enhanced ultrasound (CEUS) or analyzing cytokine expression (CEA) can help predict how well a non-union therapy will work. The study found that combining CEUS and CEA provides a promising way to predict the success of non-union therapy early on, potentially improving treatment planning and patient outcomes. The research suggests a connection between changes in specific pro-angiogenic cytokines in the blood and changes in local microperfusion. This suggests that both systemic and local factors are at play in bone regeneration.
Combining CEUS and CEA can provide an earlier and more accurate prediction of non-union therapy success.
Identifying patients likely to fail initial treatment allows for more aggressive or alternative interventions to be implemented sooner.
The study sheds light on the relationship between angiogenic cytokines, microperfusion, and bone healing, contributing to a better understanding of the biological processes involved.